Fascicular ventricular tachycardia

Articolo redatto e revisionato del Dott. Luca Moretti

Fascicular ventricular tachycardia comprises arrhythmias in which the Purkinje system and its connections participate in generating or maintaining the rhythm. The best-known form is idiopathic verapamil-sensitive reentrant tachycardia, often called Belhassen tachycardia. It can produce relatively narrow QRS complexes and mimic supraventricular tachycardia with aberrancy. However, nonreentrant fascicular forms and Purkinje arrhythmias associated with heart disease also exist and do not necessarily share the same pharmacologic response or prognosis.

The left posterior variant is the most frequent among idiopathic reentrant forms; anterior and upper septal variants are less common. Many patients have no recognizable structural heart disease and may experience episodes from a young age, but the finding is not limited to a particular age group. The apparent normality of the heart should be verified through an evaluation proportionate to the presentation. A narrow QRS complex or good tolerance does not prove a supraventricular origin.

The specific challenge is to connect ECG morphology, circuit, and therapeutic response. Involvement of the conduction system makes targeted treatment possible but requires protection of normal conduction during ablation. bundle-branch reentrant tachycardia is a distinct mechanism in which the main bundle branches form a larger circuit. Interfascicular reentry in a diseased conduction system must likewise be distinguished from the common idiopathic verapamil-sensitive form.

Functional anatomy and the fascicular reentry circuit

The His-Purkinje system rapidly distributes the impulse to the ventricles through the bundle branches, fascicles, and a peripheral network of connections. In the left ventricle, the distinction between anterior and posterior fascicles is useful but does not fully describe the organization of the network and its connections with myocardium. Purkinje fibers may extend along fibromuscular structures and papillary muscles. The apparent QRS origin reflects where activation emerges into the myocardium, while parts of the circuit may remain poorly visible on the surface ECG.

Idiopathic verapamil-sensitive reentry involves tissue with slow and decremental conduction, whose properties differ from those of ordinary rapid conduction. Sensitivity to a calcium-channel blocker does not mean that the entire Purkinje system depends on calcium current; it concerns functional components of the circuit. The exact architecture can vary, and proposed models should not be converted into a mandatory anatomical scheme. Intracardiac recordings and the response to pacing allow identification of the components actually involved.

During many posterior tachycardias, a diastolic P1 potential and a presystolic P2 potential can be distinguished. The former is associated with activation of slow, verapamil-sensitive tissue, whereas the latter reflects fascicular or Purkinje activation near the normal conduction system. The presence of P2 does not prove that the segment is indispensable to the circuit: in models supported by recordings, it may represent passive activation. Simply attempting to eliminate all Purkinje potentials would therefore be inappropriate and potentially harmful.

Propagation along slow and fast components may proceed in different directions during tachycardia and sinus rhythm. A multipolar catheter positioned along the left septum can reconstruct these sequences and separate local signals from far-field activity. Their timing relative to the QRS helps identify the phase of the circuit but does not alone prove critical participation. Activation, response to extrastimuli, entrainment when possible, and changes produced by treatment must be integrated.

False tendons, fibromuscular bands, and connections to the papillary muscles may contain portions of the involved network. Not every false tendon is pathologic, and its presence on imaging does not prove that it causes the tachycardia. When the arrhythmia is related to a papillary structure, mapping must distinguish fascicular tachycardia from a myocardial source in the muscle itself. The two conditions may have similar appearances but require different targets and pose different challenges for catheter stability.

Focal nonreentrant forms represent a separate group, often associated with abnormal automaticity in the distal Purkinje system. They may not be inducible with usual programmed stimulation and may not show typical verapamil sensitivity. Mapping seeks the earliest Purkinje activation, whereas an approach based only on pace mapping may be less precise. Postinfarction arrhythmias can also use the Purkinje network and mimic the idiopathic picture while having a different substrate and prognosis.

Electrocardiographic variants and clinical presentation

The left posterior form usually shows a right bundle branch block configuration with a superior axis and left-axis deviation. The QRS is often less wide than in many scar-related myocardial tachycardias because part of ventricular activation uses the conduction network early. Morphology points toward the variant but does not define the critical component of the circuit with certainty. Medications, baseline conduction, and fusion may modify its appearance.

The left anterior variant generally shows right bundle branch block morphology with an inferior, frequently rightward, axis. It is less common and requires mapping consistent with the anterior distribution of the involved potentials. An ablation line designed for the posterior circuit should not be applied automatically. The location of diastolic signals and their relationship to the normal conduction system guide a specific strategy, with care not to create unnecessary fascicular injury.

The upper septal form may have a narrow QRS and a normal or rightward axis, making the differential diagnosis from supraventricular tachycardias particularly challenging. It may occur spontaneously or after previous treatment of another fascicular variant. Proximity to proximal portions of the conduction system makes procedural safety especially important. A new morphology after ablation should not automatically be interpreted as a simple recurrence of the original circuit.

Forms associated with the Purkinje network of the papillary muscles broaden the traditional classification. Morphology may differ from that expected for the corresponding septal location, and the axis alone can be misleading. Intracardiac echocardiography and three-dimensional mapping help verify whether the catheter is recording from a papillary structure, a band, or the septum. Recognizing the anatomical relationship avoids attributing failure to generic resistance of the arrhythmia when the actual problem is target localization.

Clinical presentation includes rapid palpitations, dyspnea, fatigue, and occasionally presyncope. Many episodes are tolerated, but rate, duration, and cardiovascular reserve can modify the picture. An incessant or highly recurrent form can cause arrhythmia-induced cardiomyopathy, even in an initially normal heart. Syncope or major compromise requires complete evaluation and should not be minimized because of the generally favorable reputation of the idiopathic form.

Onset may be facilitated by exercise or stress, but an adrenergic relationship is neither constant nor specific. Episodes can also occur at rest, and a short interictal recording may be normal. The history should reconstruct duration, mode of termination, and prior responses to medications. A description of tachycardia terminated by verapamil is useful but does not replace the tracing: other arrhythmias may respond to the drug, and a diagnostic label may have been assigned without adequate documentation.

ECG diagnosis and distinction from other tachycardias

A twelve-lead ECG during the episode allows assessment of axis, morphology, and the atrioventricular relationship. Atrioventricular dissociation is an important sign when recognizable, as are any capture or fusion beats. One-to-one retrograde conduction is nevertheless possible and may conceal ventricular independence. A relatively narrow QRS does not exclude ventricular tachycardia and may make criteria developed primarily for very wide complexes less reliable.

Diagnostic algorithms for wide-QRS tachycardia should be interpreted cautiously in fascicular forms. Rapid initial activation through the conduction system can eliminate common signs of myocardial tachycardia. Comparison with the sinus-rhythm ECG, an unusual axis, and analysis of P waves provide additional information. Diagnosis cannot be based solely on good tolerance or young age, which modify the probabilities of causes but do not prove the origin of the rhythm.

The differential diagnosis includes supraventricular tachycardia with bundle-branch block and axis deviation, preexcited tachycardia, interfascicular reentry, and scar-associated Purkinje arrhythmias. Ischemic heart disease, baseline conduction disturbances, or impaired ventricular function make it necessary to consider forms other than the usual idiopathic one. Verapamil sensitivity is characteristic but is not sufficient evidence to exclude a structural substrate. The anatomical context remains part of the diagnosis.

Echocardiography assesses ventricular function, dimensions, and regional abnormalities; reduced function may be primary or a consequence of arrhythmic exposure. Cardiac magnetic resonance is considered when the phenotype is atypical, the baseline ECG is abnormal, or scar or inflammation is suspected. Coronary assessment and other investigations are guided by age, symptoms, and clinical probability. Idiopathic classification requires appropriate evaluation without imposing the same sequence of tests on every patient.

Ambulatory monitoring documents recurrences, runs, and any incessant activity and verifies their correspondence with symptoms. The morphology of premature ventricular contractions may be useful, but every isolated beat is not guaranteed to represent the same circuit as the tachycardia. Exercise testing can clarify behavior with activity when indicated. Blood tests and medication review look for factors that facilitate the arrhythmia or influence the safety of therapeutic options.

Genetic counseling is not automatic in the common idiopathic fascicular form. It becomes relevant when family history, conduction disturbances, or a structural phenotype suggests inherited disease. Similarly, a relatively narrow tachycardia in a patient with heart disease should not be labeled benign without clarifying the substrate. The diagnostic pathway should reach a description of both mechanism and disease rather than stop at the word fascicular.

Electrophysiological study and identification of the target

Electrophysiological study assesses the relationship among atrial activity, the His bundle, the Purkinje network, and the ventricle. In reentrant forms, tachycardia may be induced by atrial or ventricular stimulation, sometimes with adrenergic facilitation. Atrial induction does not prove a supraventricular origin: a conducted impulse can create the block and slowing needed to initiate a ventricular circuit. The induced arrhythmia should be compared with the clinical one, especially when more than one morphology appears during the procedure.

Recording P1 and P2 requires positioning that can distinguish diastolic, presystolic, and myocardial signals. In some tachycardias, the slow signal has low amplitude or cannot be recorded at the initially explored site. Its absence does not necessarily mean that the circuit is absent. The sequence along a multipolar catheter, comparison with sinus rhythm, and response to pacing help assign meaning to the potentials while avoiding indiscriminate treatment of the most prominent Purkinje signal.

Entrainment and extrastimuli can demonstrate that a region participates in the circuit. An intervention that advances a critical signal and changes subsequent timing can support a causal relationship, whereas purely passive activation follows the rhythm without governing it. Interpretation requires knowledge of capture, local conduction, and possible alternative pathways. An early potential is not automatically indispensable, and an apparently favorable response may be explained by indirect access to the circuit.

In the posterior form, the target may be a diastolic P1 potential in a region sufficiently distal to limit risk to the proximal conduction system. The consensus describes the usefulness of sites in the apical third of the septum to protect the left bundle branch and atrioventricular conduction when the circuit allows it. The strategy is not to apply energy nonspecifically to the main fascicle. The balance between efficacy and preservation of conduction must be assessed at each site.

When the tachycardia is not inducible or not tolerated, an anatomical approach based on the clinical morphology, localization of the exit, and a selected septal line may be considered. This strategy can be effective but reduces the ability to demonstrate direct participation of the target and may increase the risk of fascicular injury. The quality of preprocedural documentation therefore becomes particularly important. Incomplete mapping should not automatically be compensated for by more extensive lesions.

In anterior, upper septal, or papillary variants, mapping is adapted to the activation sequence and anatomy. Intracardiac echocardiography can confirm contact with a papillary muscle or band and improve understanding of catheter stability. In focal nonreentrant forms, the target is instead the earliest Purkinje activation during tachycardia. This distinction avoids applying an empirical ablation designed for a slow, verapamil-sensitive circuit to an automatic source.

Pharmacologic therapy and catheter ablation

Treatment of the episode depends on perfusion. In the presence of hemodynamic instability, cardioversion should not be delayed to test drug sensitivity. In a stable patient with a reasonably established verapamil-sensitive fascicular form, verapamil can terminate the tachycardia by acting on the slow component of the circuit. The expected efficacy is mechanism-specific and does not justify empirical administration to every wide-QRS tachycardia.

Intravenous verapamil can cause hypotension and worsen major systolic dysfunction; this risk is particularly relevant when the diagnosis is uncertain and the rhythm occurs in structural heart disease. In infants, nondihydropyridine calcium-channel blockers require specific precautions and should not be used according to regimens transferred from adults. Documentation of a previous response does not remove the need to reassess ventricular function and the conditions of the current episode. The choice should remain monitored and contextualized.

For prevention of recurrences, oral verapamil may be used in selected patients but does not guarantee permanent control. Adherence, tolerability, and effects on conduction influence the result. Response to other antiarrhythmic classes is variable and should be linked to the specific form. A focal nonreentrant tachycardia or a scar-related Purkinje arrhythmia may require a different strategy, so drug failure should not be interpreted only as a need to increase the dose.

Catheter ablation is a major option for symptomatic idiopathic fascicular tachycardia and may be chosen as initial treatment when appropriate. It offers the possibility of eliminating the circuit without continuous drug therapy, with high efficacy in experienced series. The decision considers symptom burden, recurrences, dysfunction, patient preferences, and location. An incessant form that impairs function makes durable control and subsequent documentation of recovery particularly important.

Energy delivery should interrupt the circuit while preserving normal conduction as much as possible. Development of hemiblock may accompany some strategies but is not a necessary endpoint of every successful ablation. Proximal or extensive lesions can cause left bundle branch block or atrioventricular block, especially in an already compromised conduction system. The risks of left-heart access, embolism, and vascular injury must be integrated with the specific risk to the conduction system rather than describing the procedure as free of possible consequences.

The endpoint includes termination of the arrhythmia and noninducibility after appropriate observation and a suitable protocol. Transient disappearance during mechanical catheter contact can mimic a definitive result and should be interpreted cautiously. The arrhythmia is not always inducible before treatment, limiting the meaning of final noninducibility. The acute result must be integrated with subsequent clinical follow-up rather than converted into a guarantee of no recurrence.

An implantable cardioverter-defibrillator is not usually indicated solely because a treatable idiopathic fascicular form is present. When heart disease, malignant events, or other substrates coexist, the indication instead follows assessment of overall risk. Eliminating a Purkinje tachycardia in a scarred heart does not necessarily eliminate the risk of other arrhythmias. The decision must distinguish success on the circuit from the prognosis of the disease that contains it.

Efficacy, recurrences, and special situations

Adult series summarized in the ablation consensus report very high efficacy for idiopathic left-sided reentrant forms, often above 95% acutely. This figure describes selected populations and centers and cannot be applied indiscriminately to proximal variants, focal forms, or pediatric patients. The probability of success depends on inducibility, identification of the circuit, and anatomy. The rarity of some variants makes estimates less precise and requires communication proportionate to the quality of the evidence.

A recurrence may reproduce the initial morphology or present with a different configuration. Recovery of conduction in the treated circuit is one possibility, but upper septal variants or other Purkinje network pathways may emerge. Comparison of ECGs and the previous map is essential before planning a repeat intervention. A narrower tachycardia after ablation should not automatically be considered supraventricular, especially if documentation suggests a new fascicular form.

In patients with dysfunction, ventricular recovery after arrhythmia control supports the presence of an arrhythmic component. Reassessment should occur over an interval compatible with remodeling and include residual burden. An incomplete response may reflect persistent exposure, more lasting injury, or concomitant heart disease. Improved function does not eliminate the need to assess any conduction disturbances caused by the procedure or already present before treatment.

In children, age, body size, tolerance, and possible evolution modify the balance between drugs and ablation. In smaller children with pharmacologic control and preserved function, the procedure may be deferred; a refractory form or one causing dysfunction requires different reasoning. Efficacy and complication rates from adult series cannot simply be transferred. Management must also consider the risks of prolonged drug exposure and the possibility of spontaneous phenotype changes at different ages.

In athletes, return to activity is assessed after confirmation of the idiopathic nature, control of symptoms, and evaluation of the response to exercise when relevant. Syncope or structural abnormalities require a broader pathway. During pregnancy, the choice and timing of therapy are adapted to maternal and fetal safety, avoiding treatment of every palpitation as recurrence of the tachycardia. Rhythm documentation remains the starting point even when the diagnosis is already known.

Follow-up is proportionate to symptoms, function, and treatment. After an effective procedure, every isolated premature beat does not need to be pursued in the absence of relevant clinical findings; prolonged palpitations, syncope, or reduced functional capacity do require reassessment. Preserving electrocardiographic documentation and explaining the mechanism helps prevent future classification errors. The favorable prognosis of the idiopathic form arises from an accurate diagnosis and coherent treatment, not merely from the relative narrowness of the QRS.